Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distribu...

FDA Recall #D-0211-2025 — Class I — December 23, 2024

Recall #D-0211-2025 Date: December 23, 2024 Classification: Class I Status: Ongoing

Product Description

Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.

Reason for Recall

Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules

Recalling Firm

Astellas Pharma US Inc. — Northbrook, IL

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

14,340 100-count bottles

Distribution

Nationwide in the USA

Code Information

Lot# 0E3353D, Exp 03/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated